Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial - PubMed (original) (raw)

Randomized Controlled Trial

. 2014 Nov 18;186(17):E649-57.

doi: 10.1503/cmaj.140764. Epub 2014 Oct 14.

Estefanía Toledo 1, Ramón Estruch 1, Emilio Ros 1, Miguel A Martínez-González 1, Olga Castañer 1, Mònica Bulló 1, Dolores Corella 1, Fernando Arós 1, Enrique Gómez-Gracia 1, Valentina Ruiz-Gutiérrez 1, Miquel Fiol 1, José Lapetra 1, Rosa M Lamuela-Raventos 1, Lluís Serra-Majem 1, Xavier Pintó 1, Josep Basora 1, José V Sorlí 1, Jordi Salas-Salvadó 1; PREDIMED Study Investigators

Collaborators, Affiliations

Randomized Controlled Trial

Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial

Nancy Babio et al. CMAJ. 2014.

Expression of concern in

Abstract

Background: Little evidence exists on the effect of an energy-unrestricted healthy diet on metabolic syndrome. We evaluated the long-term effect of Mediterranean diets ad libitum on the incidence or reversion of metabolic syndrome.

Methods: We performed a secondary analysis of the PREDIMED trial--a multicentre, randomized trial done between October 2003 and December 2010 that involved men and women (age 55-80 yr) at high risk for cardiovascular disease. Participants were randomly assigned to 1 of 3 dietary interventions: a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with nuts or advice on following a low-fat diet (the control group). The interventions did not include increased physical activity or weight loss as a goal. We analyzed available data from 5801 participants. We determined the effect of diet on incidence and reversion of metabolic syndrome using Cox regression analysis to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).

Results: Over 4.8 years of follow-up, metabolic syndrome developed in 960 (50.0%) of the 1919 participants who did not have the condition at baseline. The risk of developing metabolic syndrome did not differ between participants assigned to the control diet and those assigned to either of the Mediterranean diets (control v. olive oil HR 1.10, 95% CI 0.94-1.30, p = 0.231; control v. nuts HR 1.08, 95% CI 0.92-1.27, p = 0.3). Reversion occurred in 958 (28.2%) of the 3392 participants who had metabolic syndrome at baseline. Compared with the control group, participants on either Mediterranean diet were more likely to undergo reversion (control v. olive oil HR 1.35, 95% CI 1.15-1.58, p < 0.001; control v. nuts HR 1.28, 95% CI 1.08-1.51, p < 0.001). Participants in the group receiving olive oil supplementation showed significant decreases in both central obesity and high fasting glucose (p = 0.02); participants in the group supplemented with nuts showed a significant decrease in central obesity.

Interpretation: A Mediterranean diet supplemented with either extra virgin olive oil or nuts is not associated with the onset of metabolic syndrome, but such diets are more likely to cause reversion of the condition. An energy-unrestricted Mediterranean diet may be useful in reducing the risks of central obesity and hyperglycemia in people at high risk of cardiovascular disease.

Trial registration: ClinicalTrials.gov, no. ISRCTN35739639.

© 2014 Canadian Medical Association or its licensors.

PubMed Disclaimer

Figures

Figure 1:

Figure 1:

Prevalence of metabolic syndrome during follow-up. Error bars denote 95% confidence intervals. The changes were assessed with generalized estimating equations, and the p values shown are for the overall trend. Note: EVOO = extra-virgin olive oil.

Similar articles

Cited by

References

    1. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683–9. - PubMed
    1. Schmidt C, Bergström GML. The metabolic syndrome predicts cardiovascular events: results of a 13-year follow-up in initially healthy 58-year-old men. Metab Syndr Relat Disord 2012;10: 394–9. - PubMed
    1. Mozaffarian D, Kamineni A, Prineas RJ, et al. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2008;168:969–78. - PubMed
    1. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113–32. - PubMed
    1. Sun D-L, Wang J-H, Jiang B, et al. Metabolic syndrome vs. its components for prediction of cardiovascular mortality: a cohort study in Chinese elderly adults. J Geriatr Cardiol 2012;9:123–9. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources